Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
J Diabetes Complications. 2019 Sep;33(9):623-627. doi: 10.1016/j.jdiacomp.2019.05.009. Epub 2019 May 17.
This cross-sectional study aimed to investigate the association between arterial stiffness and chronic kidney disease (CKD) in Chinese patients with type 2 diabetes mellitus (T2DM).
This study included 1025 patients with T2DM (796 men, 229 women). The cardio-ankle vascular index (CAVI) served as an index to evaluate arterial stiffness. CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73 m and/or urinary albumin-creatine ratio ≥ 30 mg/g. Increased CAVI was defined as a value ≥9.
The mean CAVI was 8.4 ± 1.2. Among the patients, 314 (40%) had increased CAVI and 229 (22.3%) had CKD. Blood pressure, HbA1c levels, total cholesterol, low-density lipoprotein cholesterol, uric acid and CAVI were higher among patients with CKD than among those without CKD. Patients with increased CAVI were at a 1.82-fold (95% CI, 1.20-2.75; P < 0.001) higher prevalence of CKD after adjusting for other variables. The odds ratio for CKD was 2.69 (95% CI, 1.12-6.47; P = 0.027) in women and 1.62 (95% CI, 1.01-2.61; P = 0.045) in men.
Increased CAVI was independently associated with CKD in patients with T2DM. Further longitudinal studies with large sample sizes are warranted to investigate the effect of CAVI on CKD in patients with T2DM.
本横断面研究旨在探讨中国 2 型糖尿病(T2DM)患者的动脉僵硬度与慢性肾脏病(CKD)之间的关系。
本研究纳入了 1025 例 T2DM 患者(796 例男性,229 例女性)。心血管-踝血管指数(CAVI)用于评估动脉僵硬度。CKD 的定义为估算肾小球滤过率<60ml/min/1.73m²和/或尿白蛋白/肌酐比值≥30mg/g。CAVI 升高定义为≥9。
平均 CAVI 为 8.4±1.2。在患者中,314 例(40%)CAVI 升高,229 例(22.3%)患有 CKD。与无 CKD 的患者相比,CKD 患者的血压、HbA1c 水平、总胆固醇、低密度脂蛋白胆固醇、尿酸和 CAVI 更高。在校正其他变量后,CAVI 升高的患者 CKD 的患病率增加 1.82 倍(95%CI,1.20-2.75;P<0.001)。女性 CKD 的优势比为 2.69(95%CI,1.12-6.47;P=0.027),男性为 1.62(95%CI,1.01-2.61;P=0.045)。
CAVI 升高与 T2DM 患者的 CKD 独立相关。需要进一步进行具有较大样本量的纵向研究,以探讨 CAVI 对 T2DM 患者 CKD 的影响。